A detailed history of Essex Investment Management CO LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 216,722 shares of NPCE stock, worth $2.78 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
216,722
Previous 73,659 194.22%
Holding current value
$2.78 Million
Previous $820,000 176.1%
% of portfolio
0.4%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$8.25 - $10.6 $1.18 Million - $1.52 Million
143,063 Added 194.22%
216,722 $2.26 Million
Q2 2025

Aug 12, 2025

SELL
$10.34 - $18.13 $669,690 - $1.17 Million
-64,767 Reduced 46.79%
73,659 $820,000
Q1 2025

May 07, 2025

BUY
$10.04 - $14.94 $1.39 Million - $2.07 Million
138,426 New
138,426 $1.7 Million

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $319M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.